Abstract

<div>Abstract<p><b>Purpose:</b> To assess the effects of external beam radiotherapy (EBRT) on adenoviral-mediated transgene expression <i>in vitro</i> and <i>in vivo</i> and to define an optimal strategy for combining sodium iodide symporter (NIS)–mediated <sup>131</sup>I therapy with EBRT.</p><p><b>Experimental Design:</b> Expression of reporter genes [<i>NIS</i>, green fluorescent protein (<i>GFP</i>), β-galactosidase (<i>lacZ</i>), and luciferase (<i>Luc</i>)] from replication-deficient adenoviruses was assessed in tumor cell lines under basal conditions and following irradiation. The effects of viral multiplicity of infection (MOI) and EBRT dose on the magnitude and duration of gene expression were determined. <i>In vivo</i> studies were done with Ad-CMV-GFP and Ad-RSV-Luc.</p><p><b>Results:</b> EBRT increased NIS, GFP, and β-galactosidase expression in colorectal, head and neck, and lung cancer cells. Radiation dose and MOI were important determinants of response to EBRT, with greatest effects at higher EBRT doses and lower MOIs. Radiation exerted both transductional (through increased coxsackie-adenoviral receptor and integrin α<sub>v</sub>) and nontransductional effects, irrespective of promoter sequence (CMV, RSV, hTR, or hTERT). Analysis of the schedule of EBRT followed by viral infection revealed maximal transduction at 24 hours. Radiation maintained increasing radioiodide uptake from Ad-hTR-NIS over 6 days, in direct contrast to reducing levels in unirradiated cells. The effects of EBRT in increasing and maintaining adenovirus-mediated transgene expression were also seen <i>in vivo</i> using GFP- and luciferase-expressing adenoviral vectors.</p><p><b>Conclusions:</b> Radiation increased the magnitude and duration of <i>NIS</i> gene expression from replication-deficient adenoviruses. The transductional effect is maximal at 24 hours, but radioiodide uptake is maintained at an elevated level over 6 days after infection.</p></div>

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.